B. Sreedhar et al. / Tetrahedron Letters 51 (2010) 1891–1895
1895
(e) Reddy, K. M.; Babu, N. S.; Prasad, P. S. S.; Lingaiah, N. Tetrahedron Lett. 2006,
47, 7563; (f) Zhang, X.; Corma, A. Angew. Chem., Int. Ed. 2008, 47, 4358; (g) Li, P.;
Wang, L. Tetrahedron 2007, 63, 5455; (h) Wang, M.; Li, P.; Wang, L. Eur. J. Org.
Chem. 2008, 2255; (i) Sreedhar, B.; Reddy, P. S.; Krishna, C. S. V.; Babu, P. V.
Tetrahedron Lett. 2007, 48, 7882.
generation of the terminal iron-acetylide intermediate I, which
could be presumably due to the reduction of Fe3+ to a low valent
Fe2+ oxidation state.19 Iron cations also acts as Lewis acid and play
a significant role in increasing the electrophilic character of the
starting aldehyde and stabilizing the immonium salt by the coordi-
nation of the oxygen or nitrogen lone electron pair.20 The formed
iron-acetylide intermediate I, further undergoes nucleophilic addi-
tion to the immonium ion II, to yield the corresponding propargyl-
amine III and regeneration of the catalyst.
In conclusion, we have developed a simple and efficient method
for the synthesis of propargylamines via C–H activation using mag-
netically separable Fe3O4 as the catalyst under mild reaction condi-
tions. The reaction is especially effective for reactions with
aliphatic aldehydes and no additional co-catalyst or activator is re-
quired. The simple procedure for catalyst preparation, easy recov-
ery and reusability of the catalyst are expected to contribute to its
utilization for the development of benign chemical processes and
products.
15. (a) Kidwai, M.; Bansal, V.; Kumar, A.; Mozumdar, S. Green Chem. 2007, 9, 742;
(b) Kidwai, M.; Bansal, V.; Mishra, N. K.; Kumar, A.; Mozumdar, S. Synlett 2007,
1581.
16. Magnetic Fe3
O4 nanoparticles were prepared according to literature
(Polshettiwar, V.; Baruwati, B.; Varma, R. S. Green Chem. 2009, 11, 127) and
characterized by XRD and TEM.
17. Srinivas, R. A.; Ramu, E.; Ravi, V.; Sreelathaa, N. Tetrahedron Lett. 2007, 48,
7184.
18. Liang, M.; Wang, X.; Liu, H.; Liu, H.; Wang, Y. J. Catal. 2008, 255, 335.
19. (a) Berben, L. A.; Long, J. R. Inorg. Chem. 2005, 44, 8459; (b) Delfs, C. D.; Stranger,
R.; Humphrey, M. G.; McDonagh, A. M. J. Organomet. Chem. 2000, 607, 208; (c)
Nast, R. Coord. Chem. Rev. 1982, 47, 89. and references therein.
20. Bloch, R. Chem. Rev. 1998, 98, 1407.
21. Typical procedure for the synthesis of propargylamines: A mixture of aldehyde
(1 mmol), amine (1.2 mmol), alkyne (1.5 mmol), catalyst (20 mol %), and
toluene (3 mL) was taken in a round-bottomed flask and stirred at 110 °C
(aromatic aldehydes) or 80 °C (aliphatic aldehydes) temperature. After
completion of the reaction (monitored by TLC) the catalyst was easily
separated from the reaction mixture with an external magnet. After
removing the solvent, the crude material was chromatographed on silica gel
to afford the pure product. The spectroscopic data of all known compounds
were identical to those reported in the literature.6–9 Spectroscopic data for all
new compounds synthesized are reported herein.
Acknowledgments
A.S.K. and P.S.R. thank the Council of Scientific and Industrial
Research, New Delhi, for the award of Senior Research Fellowships.
1-(1-Cyclohexyl-3-(4-methoxyphenyl)prop-2-ynyl)piperidine (Table 4, entry 1):
Half-white Solid. Mp: 73–76 °C. IR (neat): 3038, 2930, 2848, 2748, 2213, 2058,
1899, 1605, 1508, 1246, 1108, 1033, 996, 830 cmÀ1 1H NMR (300 MHz, CDCl3):
.
d 0.87–1.78 (m, 15H), 2.00–2.12 (m, 2H), 2.33–2.42 (m, 2H), 2.56–2.65 (m, 2H),
3.04 (d, 1H, J = 10.0 Hz), 3.79 (s, 3H), 6.76 (d, 2H, J = 8.8 Hz), 7.31 (d, 2H,
J = 8.6 Hz). 13C NMR (75 MHz, CDCl3): d 24.6, 26.0, 26.1, 26.7, 30.4, 31.2, 39.5,
55.2, 64.3, 85.8, 85.9, 113.7, 115.8, 132.9, 159.0. ESI MS (m/z): 312 (M+H).
1-(1-Cyclohexyl-3-(3-fluorophenyl)prop-2-ynyl)piperidine (Table 4, entry 3): IR
References and notes
1. (a) Yavuz, C. T.; Mayo, J. T.; Yu, W. W.; Prakash, A.; Falkner, J. C.; Yean, S.; Cong,
L. L.; Shipley, H. J.; Kan, A.; Tomson, M.; Natelson, D.; Colvin, V. L. Science 2006,
314, 964; (b) Sun, S. H.; Murray, C. B.; Weller, D.; Folks, L.; Moser, A. Science
2000, 287, 1989; (c) Gao, J.; Zhang, W.; Huang, P.; Zhang, B.; Zhang, X.; Xu, B. J.
Am. Chem. Soc. 2008, 130, 3710; (d) Lu, J.; Yang, S. H.; Ng, K. M.; Su, C. H.; Yeh, C.
S.; Wu, Y. N.; Shieh, D. B. Nanotechnology 2006, 17, 5812; (e) Li, Z.; Wei, L.; Gao,
M.; Lei, H. Adv. Mater. 2005, 17, 1001; (f) Yu, M. K.; Jeong, Y. Y.; Park, J.; Park, S.;
Kim, J. W.; Min, J. J.; Kim, K.; Jon, S. Angew. Chem., Int. Ed. 2008, 47, 5362.
2. (a) Roca, A. G.; Morales, M. P.; O’Grady, K.; Serna, C. J. Nanotechnology 2006, 17,
783; (b) Zheng, Y. H.; Cheng, Y.; Bao, F.; Wang, Y. S. Mater. Res. Bull. 2006, 41,
525; (c) Lang, C.; Schueler, D.; Faivre, D. Macromol. Biosci. 2007, 7, 144; (d)
Majewski, P.; Thierry, B. Crit. Rev. Solid State Mater. Sci. 2007, 32, 203.
3. (a) Yoon, T. J.; Lee, W.; Oh, Y. S.; Lee, J. K. New J. Chem. 2003, 27, 227; (b)
Stevens, P. D.; Fan, J.; Gardimalla, H. M. R.; Yen, M.; Gao, Y. Org. Lett. 2005, 7,
2085; (c) Stevens, P. D.; Li, G.; Fan, J.; Yen, M.; Gao, Y. Chem. Commun. 2005,
4435; (d) Hu, A.; Yee, G. T.; Lin, W. J. Am. Chem. Soc. 2005, 127, 12486.
4. (a) Boulton, A. A.; Davis, B. A.; Durden, D. A.; Dyck, L. E.; Juorio, A. V.; Li, X. M.;
Paterson, I. A.; Yu, P. H. Drug Dev. Res. 1997, 42, 150; (b) Miura, M.; Enna, M.;
Okuro, K.; Nomura, M. J. Org. Chem. 1995, 60, 4999; (c) Naota, I.; Takaya, H.;
Murahashi, S. I. Chem. Rev. 1998, 98, 2599.
(neat): 2958, 2851, 2800, 1608, 1483, 1444, 1150, 996, 868, 780 cmÀ1 1H NMR
.
(300 MHz, CDCl3): d 0.86–1.78 (m, 15H), 1.99–2.09 (m, 2H), 2.31–2.41(m, 2H),
2.55–2.64 (m, 2H), 3.06 (d, 1H, J = 9.5 Hz), 6.96 (t, 1H, J = 7.8 Hz), 7.08–7.24 (m,
2H), 7.25 (s, 1H). 13C NMR (75 MHz, CDCl3): d 24.6, 26.0, 26.1, 26.7, 30.3, 31.2,
64.2, 85.0, 88.8, 114.7, 115.0, 118.2, 118.5, 127.5, 129.5 (d, J = 8.7 Hz). ESI MS
(m/z): 300 (M+H).
2-(3-Cyclohexyl-3-piperidin-1-yl)prop-1-ynyl)pyridine (Table 4, entry 4): IR
(neat): 3055, 2929, 2850, 2794, 2219, 1635, 1582, 1458, 1262, 1103, 993,
785 cmÀ1 1H NMR (300 MHz, CDCl3): d 0.89–1.80 (m, 15H), 1.99–216 (m, 2H),
.
2.37–2.47 (m, 2H), 2.61–2.70 (m, 2H), 3.12 (d, 1H, J = 9.8 Hz), 7.14–7.19 (m,
1H), 7.38(d, 1H, J = 7.5 Hz), 7.60(ddd, 1H, J = 2.2 Hz, 7.5 Hz, 9.8 Hz), 8.54 (d, 1H,
J = 6.0 Hz). 13C NMR (75 MHz, CDCl3): d 24.7, 26.2, 26.4, 26.9, 30.5, 31.5, 39.5,
64.3, 86.1, 88.3, 96.2, 122.2, 127.2, 135.7, 143.9, 149.8. ESI MS (m/z): 283
(M+H).
1-(1-Cyclohexyl-3-(2-nitrophenyl)prop-2-ynyl)piperidine (Table 4, entry 5): IR
(neat): 2926, 2851, 2803, 2215, 1699, 1609, 1447, 1344, 1103, 853, 746 cmÀ1
.
1H NMR (300 MHz, CDCl3): d 0.89–1.80 (m, 15H), 2.00–2.16 (m, 2H), 2.27–2.36
(m, 2H), 2.60–2.70 (m, 2H), 3.15 (d, 1H, J = 10.3 Hz), 7.36–7.43 (m, 1H), 7.47–
7.55 (m, 1H), 7.58–7.63 (m, 1H), 7.97–8.02 (m, 1H). 13C NMR (75 MHz, CDCl3):
d 24.7, 26.3, 26.9, 29.8, 30.5, 31.4, 39.5, 64.6, 85.1, 85.3, 120.4, 124.4, 127.8,
132.2, 135.1, 146.0. ESI MS (m/z): 327 (M+H).
5. (a) Jung, M. E.; Huang, A. Org. Lett. 2000, 2, 2659; (b) Murai, T.; Mutoh, Y.; Ohta,
Y.; Murakami, M. J. Am. Chem. Soc. 2004, 126, 5968.
6. Wei, C.; Li, Z.; Li, C. J. Org. Lett. 2003, 5, 4473.
7. Wei, C.; Li, C. J. J. Am. Chem. Soc. 2003, 125, 9584.
1-(1-Cyclohexyl-3-(6-methoxynapthalen-2-yl)prop-2-ynyl)piperidine (Table 4,
entry 6): White Solid. Mp: 100–103 °C. IR (neat):3057, 2931, 2849, 2795,
8. Lo, V. K. Y.; Liu, Y.; Wong, M. K.; Che, C. M. Org. Lett. 2006, 8, 1529.
9. (a) Shi, L.; Tu, Y. Q.; Wang, M.; Zhang, F. M.; Fan, C. A. Org. Lett. 2004, 6, 1001;
(b) Syeda, H. Z. S.; Halder, R.; Karla, S. S.; Das, J.; Iqbal, J. Tetrahedron Lett. 2002,
43, 6485; (c) Kabalka, G. W.; Wang, L.; Pagni, R. M. Synlett 2001, 676; (d)
Sreedhar, B.; Reddy, P. S.; Prakash, B. V.; Ravindra, A. Tetrahedron Lett. 2002, 43,
6485; (e) Wei, C.; Li, C. J. J. Am. Chem. Soc. 2002, 124, 5638; (f) Wei, C.; Mague, J.
T.; Li, C. J. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5749; (g) Gommarman, N.;
Koradin, C.; Polborn, K.; Knochel, P. Angew. Chem., Int. Ed. 2003, 42, 5763; (h)
Colombo, F.; Benaglia, M.; Orlandi, S.; Usuelli, F. J. Mol. Catal. A: Chem. 2006, 260,
128; (i) Gommermann, N.; Knochel, P. Chem. Eur. J. 2006, 12, 4380; (j) Bisai, A.;
Singh, V. K. Org. Lett. 2006, 8, 2405.
1908, 1626, 1482, 1448, 1241, 1156, 1030, 993, 846, 743 cmÀ1 1H NMR
.
(300 MHz, CDCl3): d 0.88–1.78 (m, 15H), 2.05–2.18 (m, 2H), 2.36–2.47 (m, 2H),
2.60–2.69 (m, 2H), 3.10 (d, 1H, J = 10.2 Hz, 1H), 3.91 (s, 3H), 7.02–7.11 (m, 2H),
7.41 (d, 1H, J = 8.3 Hz), 7.59 (d, 1H, J = 8.5, 7.63 (d, 1H, J = 8.8 Hz), 7.81(s, 1H).
13C NMR (75 MHz, CDCl3): d 24.6, 26.1, 26.2, 26.7, 29.6, 30.4, 31.3, 39.6, 50.7,
64.4, 86.5, 87.3, 105.7, 118.6, 119.1, 126.6, 129.1, 129.4, 130.7, 130.7, 130.9,
157.9. ESI MS (m/z): 362 (M+H).
1-(1-Cyclohexyl-3-(3-ethnylphenyl)prop-2-ynyl)piperidine 4a (Scheme 2): IR
(neat): 3302, 2928, 2851, 2800, 2749, 1593, 1473, 1447, 1229, 1104, 996,
894, 793 cmÀ1 1H NMR (300 MHz, CDCl3): d 0.84–1.78 (m, 15H), 1.99–2.11 (m,
.
10. (a) Fischer, C.; Carreira, E. M. Org. Lett. 2001, 3, 4319; (b) Sakaguchi, S.; Kubo, T.;
Ishii, Y. Angew. Chem., Int. Ed. 2001, 40, 2534; (c) Sakaguchi, S.; Mizuta, T.;
Furuwan, M.; Kubo, T.; Ishii, Y. Chem. Commun. 2004, 1638.
11. Zhang, Y.; Li, P.; Wang, M.; Wang, L. J. Org. Chem. 2009, 74, 4364.
12. (a) Chen, W. W.; Nguyen, R. V.; Li, C. H. Tetrahedron Lett. 2009, 50, 2895; (b) Li,
P.; Zhang, Y.; wang, L. Chem. Eur. J. 2009, 15, 2045.
2H), 2.32–2.41 (m, 2H), 2.55–2.64 (m, 2H), 2.99 (s, 1H), 3.05 (d, 1H, J = 10.0 Hz),
7.19–7.23 (m, 1H), 7.33–7.39 (m, 2H), 7.52 (s, 1H). 13C NMR (75 MHz, CDCl3): d
24.6, 26.0, 26.2, 26.7, 30.3, 31.2, 39.4, 20.6, 64.3, 77.5, 82.9, 85.1, 88.6, 122.1,
124.0, 128.2, 131.1, 131.9, 135.2. ESI MS (m/z): 306 (M +H).
1,3-Bis(3-cyclohexyl-3-(piperidin-1-yl)prop-1-ynyl)benzene 4b (Scheme 2): IR
(neat): 2928, 2852, 2801, 1666, 1447, 1263, 1228, 1103, 997, 755 cmÀ1 1H
.
13. Li, C. J.; Wei, C. Chem. Commun. 2002, 3, 268.
NMR (300 MHz, CDCl3): d 0.86–1.20 (m, 30H), 2.01–2.10 (m, 4H), 2.36–2.48
(m, 4H), 2.58–2.69 (m, 4H), 3.11 (d, 2H, J = 9.8 Hz), 7.16–7.22 (m, 1H), 7.31
(d, 2H, J = 9.8 Hz), 7.44 (s, 1H). 13C NMR (75 MHz, CDCl3): d 24.4, 25.9, 26.1,
26.6, 30.4, 31.2, 39.5, 64.2, 86.7, 87.7, 128.1, 131.1, 134.5, 134.5. ESI MS (m/
z): 485 (M+H).
14. (a) Li, Z.; Wei, C.; Chen, L.; Varma, R. S.; Li, C. J. Tetrahedron Lett. 2004, 45, 2443;
(b) Park, S. B.; Alper, H. Chem. Commun. 2005, 10, 1315; (c) Choudary, B. M.;
Sridhar, C.; Kantam, M. L.; Sreedhar, B. Tetrahedron Lett. 2004, 45, 7319; (d)
Kantam, M. L.; Prakash, B. V.; Reddy, C. R. V.; Sreedhar, B. Synlett 2005, 2329;